Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (313) Arrow Down
Filter Results: (313) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,340)
    • Faculty Publications  (313)

    Show Results For

    • All HBS Web  (1,340)
      • Faculty Publications  (313)

      multinational pharmaceutical companyRemove multinational pharmaceutical company →

      ← Page 13 of 313 Results →

      Are you looking for?

      →Search All HBS Web
      • Article

      Control, Performance, and Knowledge Transfers in Large Multinationals: Unilever in the United States, 1945-1980

      By: G. Jones
      This article considers key issues relating to the organization and performance of large multinational firms in the post-Second World War period. Although foreign direct investment is defined by ownership and control, in practice the nature of that "control" is far from... View Details
      Keywords: Multinational Firms and Management; Governance Controls; Performance; Business or Company Management; Ownership; Consumer Products Industry; Manufacturing Industry; United States
      Citation
      Find at Harvard
      Related
      Jones, G. "Control, Performance, and Knowledge Transfers in Large Multinationals: Unilever in the United States, 1945-1980." Business History Review 76, no. 3 (Fall 2002): 435–478.
      • June 2002 (Revised November 2005)
      • Case

      Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa

      By: Debora L. Spar
      In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details
      Keywords: Patents; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
      Citation
      Educators
      Purchase
      Related
      Spar, Debora L., and Nick Bartlett. "Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa." Harvard Business School Case 702-049, June 2002. (Revised November 2005.)
      • March 2002 (Revised October 2005)
      • Case

      Wal-Mart in 2002

      By: David B. Yoffie and Yusi Wang
      In its first quarter of 2002, Wal-Mart became the largest company on the globe (by sales) and expanded into Japan. Was the giant retailer unstoppable? This case explores Wal-Mart's top issues in fueling top- and bottom-line growth: diversification into groceries, new... View Details
      Keywords: Diversification; Expansion; Multinational Firms and Management; Corporate Strategy; Global Strategy; Retail Industry; Japan; United States
      Citation
      Educators
      Purchase
      Related
      Yoffie, David B., and Yusi Wang. "Wal-Mart in 2002." Harvard Business School Case 702-466, March 2002. (Revised October 2005.)
      • February 2002
      • Case

      Fighting AIDS and Pricing Drugs

      By: John T. Gourville
      In early 2001, makers of AIDS drugs were suing to prevent developing countries from violating their patents. The issue was driven by price. The developing countries could not afford the market price for these drugs. At the same time, the drug companies were reluctant... View Details
      Keywords: Developing Countries and Economies; Patents; Price; Strategy; Globalized Markets and Industries; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Gourville, John T. "Fighting AIDS and Pricing Drugs." Harvard Business School Case 502-061, February 2002.
      • January 2002
      • Case

      Noranda Inc.: Mining, Smelting, and Sustainability?

      By: Richard H.K. Vietor
      Noranda is a $7 billion international mining and smelting company headquartered in Canada. It has been cited for its fine environmental record. This case explores the issue of sustainability--in this case, for a mining company. Over time, and under nongovernmental... View Details
      Keywords: Cost vs Benefits; Mining; Cost Management; Multinational Firms and Management; Governing Rules, Regulations, and Reforms; Policy; Environmental Sustainability; Mining Industry
      Citation
      Educators
      Purchase
      Related
      Vietor, Richard H.K. "Noranda Inc.: Mining, Smelting, and Sustainability?" Harvard Business School Case 702-009, January 2002.
      • December 2001 (Revised January 2002)
      • Case

      Nestle S.A.

      By: Ray A. Goldberg and Hal Hogan
      Peter Brabeck wants to focus Nestle as a wellness company in the global food system and do so in a way that provides both growth in sales and margins in both developed and developing countries. View Details
      Keywords: Brands and Branding; Product Development; Supply Chain Management; Food; Multinational Firms and Management; Business Growth and Maturation; Sales; Agriculture and Agribusiness Industry; Food and Beverage Industry; Switzerland
      Citation
      Educators
      Purchase
      Related
      Goldberg, Ray A., and Hal Hogan. "Nestle S.A." Harvard Business School Case 902-419, December 2001. (Revised January 2002.)
      • September 2001 (Revised July 2009)
      • Case

      Buenos Aires Embotelladora S.A. (BAESA): A South American Restructuring

      By: Stuart C. Gilson and Gustavo A. Herrero
      In 1998, BAESA, PepsiCo's largest bottler and distributor outside North America, experienced severe financial difficulty and had to restructure its debt and business operations to avoid bankruptcy or liquidation. Based in Argentina, with operations throughout South... View Details
      Keywords: Restructuring; Borrowing and Debt; Insolvency and Bankruptcy; Bonds; Stocks; Multinational Firms and Management; Laws and Statutes; United States; Argentina; Brazil
      Citation
      Educators
      Purchase
      Related
      Gilson, Stuart C., and Gustavo A. Herrero. "Buenos Aires Embotelladora S.A. (BAESA): A South American Restructuring." Harvard Business School Case 202-009, September 2001. (Revised July 2009.)
      • 2001
      • Book

      Foreign Multinationals in the United States: Management and Performance

      By: Geoffrey Jones and Lina Galvez-Munoz
      In this volume, leading scholars in international business and business history examine the investments and performance of British, Canadian, French, German, Spanish and Japanese firms in the United States over time. They explore why so many foreign firms experience... View Details
      Keywords: Investment; Multinational Firms and Management; Books; Management; Performance; Perspective; United States
      Citation
      Find at Harvard
      Purchase
      Related
      Jones, Geoffrey, and Lina Galvez-Munoz, eds. Foreign Multinationals in the United States: Management and Performance. London: Routledge, 2001.
      • August 2001 (Revised March 2008)
      • Case

      Helios Health (A)

      By: Regina E. Herzlinger and Alfred Martin
      Helios PC system provides personalized drug information to the patients in the doctor's waiting room. It has met with considerable consumer acceptance and a very high return for the drug companies that sponsor it. What price should it charge them for the service? View Details
      Keywords: Entrepreneurship; Price; Health Care and Treatment; Information Publishing; Innovation and Invention; Product Marketing; Demand and Consumers; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Find at Harvard
      Related
      Herzlinger, Regina E., and Alfred Martin. "Helios Health (A)." Harvard Business School Case 302-022, August 2001. (Revised March 2008.)
      • July 2001 (Revised August 2005)
      • Case

      Medicines Company, The

      By: John T. Gourville
      It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details
      Keywords: Business Model; Change Management; Decision Choices and Conditions; Cost Management; Price; Product Marketing; Product Launch; Product Development; Risk and Uncertainty; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Gourville, John T. "Medicines Company, The." Harvard Business School Case 502-006, July 2001. (Revised August 2005.)
      • April 2001 (Revised September 2001)
      • Case

      Merloni Elettrodomestici: Building for a New Century

      By: Joseph L. Bower
      In 2001 a young new CEO has to develop a strategy to move his company beyond the hyper-competitive conditions of Western Europe. A major acquisition in Russia and a new Web-based service business provide interesting new directions. This case traces the development of... View Details
      Keywords: Acquisition; Corporate Entrepreneurship; Multinational Firms and Management; Growth and Development Strategy; Organizational Structure; Business Strategy; Web; Russia
      Citation
      Educators
      Purchase
      Related
      Bower, Joseph L. "Merloni Elettrodomestici: Building for a New Century." Harvard Business School Case 301-112, April 2001. (Revised September 2001.)
      • March 2001 (Revised September 2002)
      • Case

      Merck Latin America (C): Brazil

      By: Michael Beer and James Weber
      Examines Merck's change effort in Brazil from the perspective of the local employees. View Details
      Keywords: Change Management; Cross-Cultural and Cross-Border Issues; Multinational Firms and Management; Employees; Operations; Perspective; Pharmaceutical Industry; Brazil
      Citation
      Educators
      Purchase
      Related
      Beer, Michael, and James Weber. "Merck Latin America (C): Brazil." Harvard Business School Case 401-031, March 2001. (Revised September 2002.)
      • March 2001 (Revised September 2002)
      • Case

      Merck Latin America (D): Mexico

      By: Michael Beer and James Weber
      Examines Merck's change effort in Mexico from the perspective of the local employees. View Details
      Keywords: Change Management; Cross-Cultural and Cross-Border Issues; Multinational Firms and Management; Employees; Operations; Perspective; Pharmaceutical Industry; Mexico
      Citation
      Educators
      Purchase
      Related
      Beer, Michael, and James Weber. "Merck Latin America (D): Mexico." Harvard Business School Case 401-032, March 2001. (Revised September 2002.)
      • January 2001
      • Case

      Abgenix and the XenoMouse

      By: Robert J. Dolan
      Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details
      Keywords: Product Development; Marketing Strategy; Health Testing and Trials; Risk and Uncertainty; Technological Innovation; Innovation Strategy; Science-Based Business; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
      • January 2001 (Revised July 2003)
      • Case

      Pharmacyclics: Financing Research & Development

      By: Malcolm P. Baker, Richard S. Ruback and Aldo Sesia
      Pharmacyclics (NASDAQ: PCYC), a pharmaceutical company that manufactures products that will improve existing therapeutic treatments for cancer, arteriosclerosis, and retinal disease, was considering a $60 million private placement in February 2000. The company had more... View Details
      Keywords: Valuation; Cash Flow; Financing and Loans; Business Startups; Financial Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Baker, Malcolm P., Richard S. Ruback, and Aldo Sesia. "Pharmacyclics: Financing Research & Development." Harvard Business School Case 201-056, January 2001. (Revised July 2003.)
      • December 2000 (Revised January 2001)
      • Background Note

      Promise of Functional Foods, The

      By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock
      This case presents a definition of functional foods or nutraceuticals (food or food ingredients that could provide a health benefit beyond the traditional nutrients they contain), a description of some of the major obstacles to their commercialization and... View Details
      Keywords: Food; Private Sector; Public Sector; Health; Product Development; Production; Commercialization; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Find at Harvard
      Related
      Goldberg, Ray A., Carin-Isabel Knoop, and Laure Mougeot Stroock. "Promise of Functional Foods, The." Harvard Business School Background Note 901-013, December 2000. (Revised January 2001.)
      • October 2000 (Revised June 2017)
      • Case

      Vyaderm Pharmaceuticals: The EVA Decision

      By: Robert Simons and Indra A. Reinbergs
      In 2016, the new CEO of Vyaderm Pharmaceuticals introduces an Economic Value Added (EVA) program to focus the company on long-term shareholder value. The EVA program consists of three elements: EVA centers (business units), EVA drivers (operational practices that... View Details
      Keywords: Compensation and Benefits; Employee Relationship Management; Economic Growth; Economic Systems; Management; Motivation and Incentives; Organizational Design; Organizational Structure; Performance Evaluation; Decision Choices and Conditions; Pharmaceutical Industry; Washington (state, US)
      Citation
      Educators
      Purchase
      Related
      Simons, Robert, and Indra A. Reinbergs. "Vyaderm Pharmaceuticals: The EVA Decision." Harvard Business School Case 101-019, October 2000. (Revised June 2017.)
      • October 2000 (Revised November 2005)
      • Case

      Li & Fung (A): Internet Issues

      By: F. Warren McFarlan and Fred Young
      This case looks at the issues facing a Hong Kong-based trading company, which links hundreds of factories in India and Asia with major customers like Gap and the Limited in Europe and in the United States. The company has recently launched a dot-com operation to allow... View Details
      Keywords: Information Technology; Internet and the Web; Multinational Firms and Management; Distribution Channels; Logistics; Networks; Markets; Supply Chain; Retail Industry; Hong Kong; India; Europe; United States
      Citation
      Educators
      Purchase
      Related
      McFarlan, F. Warren, and Fred Young. "Li & Fung (A): Internet Issues." Harvard Business School Case 301-009, October 2000. (Revised November 2005.)
      • September 2000
      • Case

      Jardines: Tapping the Asian E-Commerce Market

      By: F. Warren McFarlan, Melissa Dailey and Fred Young
      "We have made significant progress in reshaping the group in the current cycle of change," announced the homepage of Jardine Matheson & Co.'s web site. Percy Weatherall, newly appointed managing director of the company, knew all too well about change. In his previous... View Details
      Keywords: Corporate Entrepreneurship; Decisions; Information Technology; Corporate Strategy; Technology Adoption
      Citation
      Find at Harvard
      Related
      McFarlan, F. Warren, Melissa Dailey, and Fred Young. "Jardines: Tapping the Asian E-Commerce Market." Harvard Business School Case 301-045, September 2000.
      • 2000
      • Book

      Merchants to Multinationals

      By: Geoffrey Jones
      This book examines the evolution of multinational trading companies from the eighteenth century to the present day. During the Industrial Revolution, British merchants established overseas branches which became major trade intermediaries, and later engaged in foreign... View Details
      Keywords: Competency and Skills; Trade; Foreign Direct Investment; Multinational Firms and Management; Corporate Governance; Growth and Development; Human Resources; Information Management; Relationships; Corporate Strategy; Africa; Asia; Latin America
      Citation
      Find at Harvard
      Purchase
      Related
      Jones, Geoffrey. Merchants to Multinationals. Oxford: Oxford University Press, 2000. (Winner of Newcomen-Harvard Book Award Given once every three years to the best work in the field of business history published in the United States.)
      • ←
      • 13
      • 14
      • 15
      • 16
      • →

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.